For 15 years I assumed period pain was just my fault. Then I read the 2018 paper that changed everything.

I'm 32. The cramps started at 17. For fifteen years I'd taken whatever the pharmacy at Boots had in stock, applied a heating pad my mum bought from Argos in 2011, and assumed at some point that this was simply how my body worked. Then a friend who works in obstetric research handed me a paper, and I realised I'd been fighting the wrong thing the entire time.

What follows is what I wish someone had told me in sixth form. It's a chronological account of how I came across the research, what the science actually says about period pain biology, what most over-the-counter solutions are missing, and what I ended up using once I understood the mechanism properly.

To set expectations upfront: I bought the wearable I'm going to mention with my own money. It worked for me on the cycles I tested it on. I'm including specific details because the science is what shifted my view, not the marketing. If you want to skip ahead to the practical part, scroll to the section titled "What I started looking for." But the biology is worth understanding first, because it explains why so many of the obvious solutions only get you partway there.

The biology nobody explained at school

Primary dysmenorrhea, the medical term for period cramps without underlying pathology, is what one in three British women experience monthly. The 2024 NHS estimates put the figure at 31% of menstruating women reporting "moderate to severe" cramps that affect their ability to function. Approximately one in twelve report pain severe enough to require sick leave at least once per cycle.

The official explanation, the one that gets summarised in secondary school biology lessons, is that the uterus contracts to shed its lining. True, but incomplete.

Here is what the medical literature actually shows.

The trigger is a chemical your uterus produces called prostaglandin F2-alpha. In moderate amounts, it does its job and you barely notice. In higher concentrations, which roughly one in three women produce, it does two things at once.

First, it tells the uterine muscle to contract harder and more rhythmically than usual. That is the cramping you feel.

Second, and this is the part nobody talks about, prostaglandin F2-alpha constricts the blood vessels feeding oxygen to that same muscle.

So while your uterus is contracting harder than it has all month, it is simultaneously starving for oxygen. The muscle is being asked to work overtime under hypoxic conditions. That is why your cramps feel like they radiate. Why you sweat. Why you sometimes feel light-headed or nauseated. Why a 400mg dose of ibuprofen sometimes does not fully cover it.

The technical name in the literature is "the prostaglandin lockdown". The chemical squeezes the muscle and shuts off the oxygen feeding it at the same instant. You're not weak. You're not soft. The mechanism is just nastier than what the diagrams in your secondary school biology textbook showed.

Why heating pads only fight half the battle

Heating pads have been the household answer for cramps in British homes for at least seventy years. They feel like they help. They do help. But they only address one side of the prostaglandin lockdown.

Here's why.

Localised heat triggers a process called vasodilation: the constricted blood vessels relax and open back up. Oxygen flows again. The muscle stops being hypoxic. The "step two" of the cramp mechanism is being addressed.

But heating pads have three problems.

First, they don't hold a calibrated temperature. The therapeutic range, according to clinical literature, is 38–45°C continuous. Most household heating pads start at maybe 42°C, drop to 36°C within an hour, and lose meaningful therapeutic effect after about ninety minutes. You'd need to swap them every cycle of relief.

Second, they tether you to a sofa. You can't take a heating pad to the office, a wedding, a long-haul flight, or the school run. Cramps don't respect your calendar. Your relief tool needs to move with you.

Third, they don't address the muscular contraction itself. They reduce the vascular component. They do nothing for the rhythmic muscle squeeze that the prostaglandin chemical is causing. Which is why so many of us reach for ibuprofen on top of the heating pad.

That's why you feel a heating pad helping, and why you still take ibuprofen alongside it. They're addressing different parts of the problem, and neither one fully covers both.

Why ibuprofen has its own trap

Ibuprofen is the other half of most British women's cramp protocol. It works by inhibiting prostaglandin production at the source. Less prostaglandin, less contraction, less pain. For most women it works, at least partially.

But there's a catch that gets glossed over.

The therapeutic dose for primary dysmenorrhea is 400–800mg every six hours. Sustained over many cycles across decades, that's a meaningful body load. Long-term high-dose NSAID use is associated with stomach lining damage, kidney function decline, and elevated cardiovascular risk in some demographics, according to NHS guidance and 2021 BMJ analyses.

A 2019 paper in the British Journal of General Practice found that women with severe dysmenorrhea were taking on average 2,400mg of ibuprofen across each cycle, multiplied across thirty years of cycling. That's a body load most GPs would call concerning if asked directly. Most aren't asked directly, because most women don't bring up cramps at their GP appointments. The pain has been so normalised that it doesn't feel like something worth raising.

Ibuprofen also doesn't address blood flow. It blocks the chemical signal but does not restore oxygen to the muscle. Which is why women on ibuprofen still feel residual ache, fatigue, and that "deep pull" sensation. The muscle is still hypoxic, even when the pain spike has been blunted.

The 2018 Nature paper

Here's where the story shifted for me.

In December 2018, two researchers, Jo and Lee, published a meta-analysis in Scientific Reports, the open-access journal of the Nature publishing group. They reviewed three randomised controlled trials. Combined sample: 274 women with primary dysmenorrhea.

The intervention: continuous heat at 38–45°C, applied to the lower abdomen, for the first eight to twelve hours of menstrual cycling.

The control: standard ibuprofen dosing at 400mg every six hours.

The finding wasn't "comparable." It wasn't "similar." It was equivalent. Continuous calibrated heat performed as well as ibuprofen for primary dysmenorrhea, measured by VAS pain scores at hours four, eight, and twenty-four post-onset.

Most heating products on the British high street can't deliver that. ThermaCare patches lose useful heat after roughly thirty minutes. Heating pads fluctuate. Hot water bottles cool quickly. The 2018 paper specifically found that intermittent or fluctuating heat produced markedly worse results than the continuous calibrated kind.

This was the first thing that genuinely shifted how I thought about cramps. Not heat in general. Continuous heat at a specific temperature range. That distinction was doing all the work in the data.

The third mechanism: gate-control vibration

Then I came across a separate body of research. This one was on gate-control theory, originally proposed by Melzack and Wall in 1965 in the journal Science, with a body of follow-up research running into 2024.

The simplified version: pain signals travel through your spinal cord on slow nerve fibres, called C-fibres. Touch and vibration signals travel on faster nerve fibres, called A-beta fibres. When the faster fibres fire, they "close the gate" at the spinal cord, blocking the slower pain signals from reaching the brain.

This is why rubbing a stubbed toe makes it hurt less. The vibration of the rub is reaching your brain before the pain does. The same principle is what makes massage chairs feel relieving, what makes weighted blankets help anxiety-related muscle tension, and what makes targeted vibration meaningful in clinical pain management.

Calibrated vibration applied to the lower abdomen during cramps does the same thing. It doesn't address the chemical. It doesn't address the blood flow. It addresses the signal.

So now we have three failure points in primary dysmenorrhea. The chemical (which ibuprofen blocks). The vascular constriction (which heat opens back up). The pain signal travelling to the brain (which vibration interrupts at the spinal cord).

Most British women have access to one or two of these mechanisms at home. A heating pad addresses one. Ibuprofen addresses another. Almost nothing widely available on the British high street addresses the third alongside the other two.

What I started looking for

Once I understood the biology, I went looking for a product that would address all three mechanisms simultaneously. The criteria I wrote down looked like this.

Continuous heat at 38–45°C, sustained for at least four hours on a single charge. Add-on calibrated vibration, ideally with multiple intensity levels for the harder days. Wearable to work, not strapped to a sofa. No subscription model, no recurring patches, no consumable refills designed to lock me into a monthly purchase. Something I could buy once, charge with a USB-C cable, and keep for the next decade of cycles.

The market for this category in the UK in early 2026 looks like this.

I almost gave up. The British market is genuinely thin in this category. Then a friend in obstetric research mentioned a brand operating out of Brooklyn that had recently begun shipping into the UK called peryode.

peryode

Full disclosure once more. I bought one with my own money, used it for two cycles, and am writing about it because the science checks out and the product worked for me. I have no commercial relationship with the brand.

peryode (lowercase, the brand insists) makes one product, the DualWave Relief Belt. The mechanism is exactly what I had been looking for.

A PTC ceramic heat element, calibrated to 38–45°C, continuous and self-regulating. The PTC technology means it physically can't overheat, the ceramic resistance increases with temperature, capping the output at the calibrated range. Calibrated vibration, three intensity levels, two pulse patterns, applied alongside the heat. 5 hours 7 minutes of runtime on heat-only mode, independently tested. 91 seconds from cold start to therapeutic temperature. 4mm profile under clothing. USB-C charging from any phone charger. No subscription. One belt, one purchase, used for years.

The brand was started by a woman in Brooklyn who had cramps for fifteen years (yes, like me) and got tired of nothing on the shelf fully working. She worked with engineers and obstetric researchers to spec the heat range to match the 2018 paper. The first prototypes shipped to friends and family in late 2024. Wider US launch was 2025. UK availability started in early 2026, fulfilled with Royal Mail tracked delivery.

What it's actually like

I tested it on the first day of my cycle, which is historically my worst day.

I charged it for two hours from a standard phone charger. Wrapped it under a thin t-shirt before I'd even noticed cramps starting, mostly because I was curious about the discreet-under-clothing claim. About 45 minutes in, I realised something. The cramping that usually had me curled up by mid-morning hadn't started. I checked my notes from previous cycles. By 11am on Day One, I'm typically dosing 600mg of ibuprofen. That morning, I hadn't taken any.

By the end of the day I had taken 200mg, more out of habit than need.

Day Two and Three I wore it intermittently. When the deeper aches started, I clicked it on for an hour, then off. I worked from a coffee shop, a co-working space in Hackney, and a friend's lounge across those two days. Nobody noticed it. The 4mm profile is real. It's about the thickness of a paperback, sitting low across the abdomen under any normal layer of clothing. I wore it under a fitted dress to a dinner without anyone commenting.

The vibration setting I used the most was the lowest one. The brand calls it "ambient." It's not noisy, it's not buzzy in a distracting way. It's more like the constant hum of a quiet appliance against your skin, doing its work in the background. I forgot it was on, twice.

The honest caveats

Three things worth flagging, because the brand themselves do.

One. This is not a treatment for endometriosis. It addresses the mechanical pain components of cramping. It doesn't change the underlying disease. Reviewers with endo report functional improvement on bad days, not elimination of symptoms. The brand says this clearly on their site, which I appreciate.

Two. It's not for use during pregnancy. Direct heat applied to the abdomen during pregnancy is contra-indicated. The brand says this too.

Three. It doesn't work for everyone. Period pain has many causes. Fibroids, adenomyosis, endo, IBS overlap, pelvic floor dysfunction. No single tool addresses all of them. The 2018 paper specifically tested primary dysmenorrhea, cramps without underlying pathology. If your pain is from something else, see a GP first. peryode's 60-day refund is there partly for women who try it and find it isn't the right tool for their specific situation.

The price, in pounds

The Relief Kit, which is the most popular configuration with two extra gel pads and a carrying case, is £74.99 including VAT. Free UK shipping above £69. Delivery via Royal Mail tracked, typically three to five working days.

For perspective: the ThermaCare patches I'd been buying came to roughly £14 per cycle, or about £168 per year. The peryode belt pays for itself versus patches alone in roughly six months. If you compare it against the productive-day-loss research from a 2019 BJGP paper, which estimated £750+ in annual lost wages for women with severe dysmenorrhea, the comparison gets even more favourable.

There's also a Starter configuration at £59.99 (just the belt, the cable, and the quick start guide) and a Complete Protocol at £94.99 (adds adhesive heat patches and a recovery guide). All four configurations come with the same 60-day promise.

The 60-day promise

Worth restating because the femcare category trained women to expect the opposite.

peryode's promise reads: one email if it doesn't work for you. No forms. No questionnaires. No "please give it one more cycle." Refund processed within 48 business hours. You don't ship the belt back. You keep it, donate it, gift it, recycle it, whatever you want. They explicitly don't pay you to mail back a used medical device because that would defeat the purpose of risk-free trial.

I haven't returned mine, so I can't speak to it from experience. I went in expecting the typical "money-back guarantee" gauntlet of forms and follow-ups. The way they've structured it is meaningfully different.

Final note

I'm 32 and I now have a tool that addresses what's actually happening in my body during my cycle. I wish I'd had this at 17. I wish someone had explained the prostaglandin mechanism to me at any point during my education. I wish the heating pad in my mum's airing cupboard had been an actual calibrated 38–45°C continuous device, and not the fluctuating not-quite-warm-enough relic from 1980s Argos that it actually was.

But the science is published. The wearable exists. The company seems to take their refund commitment seriously. And it is, finally, available on this side of the Atlantic.

If you've been managing cramps for years and felt like nothing fully works, this is worth fifteen minutes on their site. The 2018 paper alone is worth reading even if you decide the wearable isn't for you. Knowing the mechanism changes the way you think about the pain. That part, at least, is free.